NCT06275516Recruiting
Safety and Efficacy of Multisensory Stimulation Virtual Reality for Stroke Patients.
A Single-blind Randomized Controlled Trial of Multisensory Stimulation Virtual Reality to Improve Motor and Cognitive Function in Stroke Patients
Source: ClinicalTrials.gov · Last updated 19 Mar 2026
Brief summary (registry, in English)
This was a single-blind randomized controlled trial of multisensory stimulation virtual reality to improve motor and cognitive dysfunction in stroke patients.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 17 Feb 2024
- Start date
- 20 Mar 2024
- Primary completion date
- 30 Jun 2026
- Lead sponsor
- First Affiliated Hospital of Chongqing Medical University
- Diseases
- Stroke
- NCT number
- NCT06275516
What you commit to
- Study type: Interventional
- Planned participants: 40
- From 20 Mar 2024 to the primary completion date, 30 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with unrepaired cranial bone flaps or metallic implants following brain surgery.
Other illness
- Presence of other conditions affecting lower limb motor function, such as osteoarthritis or recent lower limb fractures.
- History of severe psychiatric disorders, other neurological diseases, acute cardiopulmonary dysfunction, multiple organ failure, brain tumours, or epilepsy.
Other
- Severe visual or hearing impairments.
- Pregnant or breastfeeding women.
Who the study is looking for
- The first onset of stroke is diagnosed and confirmed according to the requirements of stroke
- The Fugl-Meyer Assessment of Lower Extremity (FMA-LE) is less than 34.
- 18-85 years of age.
- Able to walk with minor assistance
- MMSE score of 20-30 and ability to understand and follow instructions during the trial
- Able to sign an informed consent form.
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The First Affiliated Hospital of Chongqing Medical University, First Branch Coordinator of this site? Confirm its status | Chongqing | China | Recruiting |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.